Nanoscope Therapeutics, Inc. — Form D
Nanoscope Therapeutics, Inc. of BEDFORD, TX, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-22. The offering totals $16.1M, of which $12.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-07-22
- Form: D
- Accession: 0001818399-20-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $16.1M
- Amount sold: $12.8M
- Remaining: $3.3M
- Investors: 12
- Date of first sale: 2020-07-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-371542
Issuer
- Name: Nanoscope Therapeutics, Inc.
- CIK: 0001818399
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1312 BROWN TRAIL, BEDFORD, TX, 76022
- Phone: 817.719.2692
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Sulagna Bhattacharya | Director | Bedford, TX |
| Alvaro Guillem | Director | Southlake, TX |
| Samarendra Mohanty | Director | Bedford, TX |
| Sulagna Bhattacharya | Executive Officer | Bedford, TX |
| Samarendra Mohanty | Executive Officer | Bedford, TX |
More